Ryan Gierke
Impact in
- Modeling and Simulation top 0.5%
- COVID-19 epidemiological studies
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Epidemiology 28
- Pneumonia and Respiratory Infections 27
- Respiratory viral infections research 15
- Pneumocystis jirovecii pneumonia detection and treatment 4
-
- Immunodeficiency and Autoimmune Disorders 7
- Co-authors
- Tamara Pilishvili (26 shared papers)Stephanie R. Bialek (3 shared papers)Tami H. Skoff (3 shared papers)Michelle M. Hughes (3 shared papers)Nancy A. Chow (3 shared papers)Matthew D. Ritchey (3 shared papers)Aron J. Hall (3 shared papers)Lucy A. McNamara (1 shared paper)
- Journals
- MMWR Morbidity and Mortality Weekly Report (10 papers)Open Forum Infectious Diseases (7 papers)The Journal of Infectious Diseases (2 papers)Clinical Infectious Diseases (2 papers)The Pediatric Infectious Disease Journal (2 papers)
- Partner nations
- United StatesUgandaGambia
In The Last Decade
Ryan Gierke
33 papers receiving 5.8k citations
Ryan Gierke's Hit Papers
Peers
Comparison fields: 5 of 162
- Modeling and Simulation 464
- Infectious Diseases 1.7k
- Epidemiology 1.8k
- Obstetrics and Gynecology 338
- Health 356
Countries citing papers authored by Ryan Gierke
This map shows the geographic impact of Ryan Gierke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Gierke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Gierke more than expected).
Fields of papers citing papers by Ryan Gierke
This network shows the impact of papers produced by Ryan Gierke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Gierke. The network helps show where Ryan Gierke may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Gierke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 Hit paper breakdown → | 2020 | 1670 |
| 2 | Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020 Hit paper breakdown → | 2020 | 1037 |
| 3 | Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 Hit paper breakdown → | 2020 | 1017 |
| 4 | Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices. Hit paper breakdown → | 2014 | 559 |
| 5 | 2020 | 348 | |
| 6 | Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices Hit paper breakdown → | 2019 | 255 |
| 7 | Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 Hit paper breakdown → | 2022 | 228 |
| 8 | 2015 | 168 | |
| 9 | Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) | 2013 | 140 |
| 10 | 2016 | 117 | |
| 11 | Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023 Hit paper breakdown → | 2023 | 82 |
| 12 | 2016 | 74 | |
| 13 | Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Hit paper breakdown → | 2024 | 47 |
| 14 | Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Hit paper breakdown → | 2025 | 42 |
| 15 | 2022 | 36 | |
| 16 | 2020 | 29 | |
| 17 | 2020 | 28 | |
| 18 | 2019 | 24 | |
| 19 | 2019 | 22 | |
| 20 | 2024 | 18 |
About Ryan Gierke
Ryan Gierke is a scholar working on Epidemiology, Immunology, General Health Professions, Infectious Diseases and Microbiology, having authored 35 papers that have together received 6.0k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (27 papers), Respiratory viral infections research (15 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Bacterial Infections and Vaccines (4 papers), Child and Adolescent Health (4 papers), COVID-19 and healthcare impacts (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Modeling and Simulation (464 citations), Infectious Diseases (1.7k citations), Epidemiology (1.8k citations), Obstetrics and Gynecology (338 citations) and Health (356 citations). Ryan Gierke has collaborated with scholars based in United States, Uganda and Gambia. Frequent co-authors include Tamara Pilishvili, Stephanie R. Bialek, Tami H. Skoff, Michelle M. Hughes, Nancy A. Chow, Matthew D. Ritchey, Aron J. Hall, Lucy A. McNamara, Cynthia G. Whitney and Nancy M. Bennett. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report, Open Forum Infectious Diseases, The Journal of Infectious Diseases, Clinical Infectious Diseases and The Pediatric Infectious Disease Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.